在1型糖尿病中对胰岛素输液部位的评估:DERMIS研究
Andrea Kalus1, Michi M Shinohara1,2, Ruikang Wang3
1Division of Dermatology, Department of Medicine, School of Medicine, University of Washington, Seattle, WA.
Diabetes care
|July 14, 2023
概括
针对1型糖尿病的持续皮下胰岛素输注 (CSII) 可能会引起皮肤反应. 这些反应,包括炎症和组织变化,可能导致输液部位失效.
科学领域:
- 皮肤病学 皮肤病学
- 内分泌学 在内分泌学.
- 医疗器械技术 医疗器械技术
背景情况:
- 持续的皮下胰岛素输注 (CSII) 越来越多地用于1型糖尿病的管理.
- 位故障很常见,但根本的皮肤变化并未得到充分理解.
研究的目的:
- 为了评估与CSII的慢性胰岛素输注相关的皮肤变化.
- 研究非侵入性光学方法和活检在评估这些变化的作用.
主要方法:
- 使用光学连贯断层扫描 (OCT),OCT血管造影 (OCTA) 和皮肤活检的横截面研究.
- 当前输液站点,回收站点和对照站点的比较.
主要成果:
- OCT和OCTA显示了位的炎症和血管密度增加.
- 组织学分析显示皮肤结构发生变化,纤维化,炎症 (包括乙氨基酸细胞) 和脂肪亡.
- 免疫组织化学表明ILGF-I和TGF-β3染色的差异.
结论:
- 研究结果表明,过敏敏感化是CSII部位的常见反应,可能是由于胰岛素防腐剂,设备材料或粘合剂.
- 炎症反应可能导致组织变化,导致频繁的输液部位失效.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
213
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213
Insulin Formulations: Types and Delivery
232
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
232
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Pulse Assessment Sites
1.2K
Pulse assessment sites are crucial in evaluating a patient's cardiovascular health. By assessing the pulsations of arteries at specific anatomical locations, healthcare professionals can gather valuable information about blood flow, heart rate, and peripheral circulation. Understanding these pulse assessment sites is essential for conducting comprehensive cardiovascular evaluations and monitoring patients' overall health. These sites are strategically chosen due to the accessibility and...
1.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K


